Plasma levels of GlycA, a pro-inflammatory glycoprotein biomarker, associate with an increased risk of microvascular complications in patients with type 2 diabetes (Zodiac-62)
Arno R. Bourgonje, Amarens van der Vaart, Eke G. Gruppen, Harry van Goor, Stephan J. L. Bakker, Margery A. Connelly, Peter R. van Dijk, Robin P.F. Dullaart
Topics & Concepts
BiomarkerDiabetes mellitusMedicineType 2 diabetesGlycoproteinInternal medicineEndocrinologyImmunologyBioinformaticsBiologyBiochemistryDiabetes and associated disordersGlycosylation and Glycoproteins ResearchDiabetes, Cardiovascular Risks, and Lipoproteins